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Summary 
Hypothalamic tanycytes are considered to function as sensors of peripheral metabolism [1]. To 
facilitate this role they express a wide range of receptors, including fibroblast growth factor receptor 
1 (FGFR1). Using a monoclonal antibody (IMC-H7) that selectively antagonizes the FGFR1c isoform 
[2], we investigated possible actions of FGFR1c in a natural animal model of adiposity, the Siberian 
hamster. Infusion of IMC-H7 into the third ventricle suppressed appetite and increased energy 
expenditure. Likewise, peripheral treatment with IMC-H7 decreased appetite and body weight, and 
increased energy expenditure and fat oxidation. A greater reduction in body weight and caloric 
intake was observed in response to IMC-H7 during the long-day fat state as compared to the short-
day lean state. This enhanced response to IMC-H7 was also observed in calorically-restricted 
hamsters maintained in long days, suggesting that it is the central photoperiodic state rather than 
the peripheral adiposity that determines the response to FGFR1c antagonism. Hypothalamic thyroid 
hormone availability is controlled by deiodinase enzymes (DIO2 and DIO3) expressed in tanycytes, 
and is the key regulator of seasonal cycles of energy balance [3, 4]. Therefore, we determined the 
effect of IMC-H7 on hypothalamic expression of these deiodinase enzymes. The reductions in food 
intake and body weight were always associated with decreased expression of DIO2 in the 
hypothalamic ependymal cell layer containing tanycytes. These data provide further support for the 
notion the tanycytes are an important component of the mechanism by which the hypothalamus 
integrates central and peripheral signals to regulate energy intake and expenditure. 
 
Results and Discussion 
Expression of FGFR1c in tanycytes 
Mammals that have evolved in temperate and polar environments generally display profound 
seasonal cycles in energy balance comprising changes in appetite, energy expenditure and fat 
deposition [5]. Analysis of hypothalamic function in seasonal mammals is a strategy to identify novel 
pharmacological targets for the treatment of obesity and its comorbidities [4, 6]. Recently, it has 
become clear that hypothalamic tanycytes play a pivotal role in generating seasonal cycles. Annual 
changes in photoperiod regulate many genes in the ependymal cell layer that contains the tanycyte 
cell soma, including nestin, GPR50, and those encoding processing enzymes and transporters for 
thyroid hormone and retinoic acid [7-9].  In situ hybridization revealed a high level of expression of 
FGFR1c in this cell layer (Figure 1A, Figure S1), consistent with previous quantitative PCR studies in 
the mouse [10]. FGFR1c is a member of the tyrosine kinase FGF receptor family that are thought to 
play diverse roles in the development, growth and regeneration of tissue [11]. Antibody-mediated 
targeting of FGFR1c reduces body weight, fat mass and insulin resistance in animal models of obesity 
and type II diabetes [2, 12, 13]. The aim of the current studies was to investigate the role of FGFR1c 
in the regulation of body weight, food intake and metabolism using a monoclonal antibody 
antagonist (IMC-H7) that selectively targets the FGFR1c isoform [2].  
 Although IMC-H7 was shown to bind specifically in the mediobasal hypothalamus of mice 
[2], and was originally characterized as an antagonist on the basis of its ability to block binding of 
FGF2 to FGFR1c expressed in a myoblast cell line [2], we confirmed its ability to target tanycytes by 
testing its activity in primary cultures [14]. Ligand-mediated activation of tyrosine kinase FGFR is 
characterized by induction of MAP kinase (ERK1/2) and Akt signalling, so we determined its ability to 
inhibit signalling of a canonical FGFR1 ligand, FGF2. FGF2 (10nM) treatment increased the 
phosphorylation of ERK1/2 and Akt in rat primary tanycytes (Figure 1B-E). IMC-H7 itself did not 
increase phosphorylation of ERK1/2 or Akt either acutely or following a 1h incubation period (Figure 
1B-E), however, IMC-H7 was able to block FGF2-mediated phosphorylation of ERK1/2 and Akt when 
pre-incubated with the primary cell cultures for 1h prior to adding FGF2 (Figure 1B-E). Our previous 
immunohistochemical and PCR analyses of the primary cultures derived from microdissected 
ependymal walls suggests they are highly enriched for tanycyte markers (vimentin) but not for 
markers of astrocytes (GFAP) or neighbouring pars tuberalis (TSH) [14]. We therefore infer that 
IMC-H7 is exerting its antagonistic action via binding to receptors on tanycytes. 
 We determined the effect of FGFR1c blockade in vivo by infusing 0.5g IMC-H7 via an 
intracerebroventricular cannula.  Such treatment caused a significant reduction in body weight that 
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had not returned to baseline by 96h after treatment (Figure 1F). This reflected a significant reduction 
in food intake over the first 48h after infusion (Figure 1G) that did not return to baseline until 72h 
after infusion.  It also caused an increase in energy expenditure from 24-72h post infusion (Figure 
1H) that was associated with a trend (P=0.07) towards increased fat oxidation during the dark phase 
(Figure 1I). Although fasting plasma leptin concentrations were not affected 96h after IMC-H7 
administration (Figure 1J), insulin concentrations were decreased (Figure 1K). 
 
Systemic FGFR1c blockade mimics central responses 
Tanycytes form a structural component of the blood-brain barrier in that their end feet appose 
endothelial cells surrounding capillaries in the median eminence [15]. They express a wide range of 
hormone receptors and nutrient sensors that underpin their role in mediating metabolic signalling to 
the hypothalamus [16, 17]. The objective of this study was to compare peripheral effects of FGFR1c 
blockade to the central effects. There was a dose-dependent decrease in body weight following 
systemic IMC-H7 treatment (Figure 2A). This persisted for the first 5-6 days after infusion in 
hamsters treated with the highest dose (3mg/kg) of IMC-H7. This long-term action is consistent with 
the 3-5 day half-life of a similar monoclonal antibody antagonist, as previously estimated in mice [2]. 
The weight loss reflected a substantial suppression of food intake (Figure 2B), but also an increase in 
energy expenditure in hamsters treated with the highest dose of IMC-H7, as assessed on day 6-7 
after the start of treatment (Figure 2C).  At this point fat oxidation was significantly increased (Figure 
2D), and carbohydrate oxidation decreased (Figure 2E). Analysis of body composition using 
computed tomography revealed that the loss of body weight induced by FGFR1c blockade reflected 
a significant reduction in the volume of adipose tissue (Figure 2F, G).  
 
Photoperiodic regulation of responses to FGFR1c blockade 
We repeated the dose-response study in hamsters acclimatised to short photoperiods (SD) for 12 
weeks to induce a lean hypophagic state, and noted that the responses to IMC-H7 were attenuated 
(Figure S2). We therefore compared directly responses to IMC-H7 in age-matched hamsters 
previously exposed to long or short photoperiods (Figures 2H-J, 3). Treatment with IMC-H7 at a dose 
of 3 mg/kg decreased body weight in hamsters maintained in both photoperiods (Figure 3A, B), but 
again the effects of IMC-H7 were more pronounced in hamsters maintained in their LD fat state: 
body weight was reduced by ~12% in hamsters in LD compared to ~7% reduction in hamsters 
maintained in SD (Figure 3A, B). Similarly, there were clear suppressive effects of IMC-H7 on food 
intake throughout the treatment period in hamsters maintained in LD (Figure 3C) and on days 2 and 
3 in hamsters in SD (Figure 3D). Treatment with IMC-H7 significantly increased daily energy 
expenditure in animals maintained in LD (Figure 3E). Importantly, similar to the pilot dose-response 
studies, treatment with IMC-H7 did not significantly affect energy expenditure in hamsters in SD 
(Figure 3F). Forty-eight hours after IMC-H7 treatment began there was a clear switch in metabolic 
fuel utilization, that is, a significant increase in fat oxidation (Figure 3G, H) and a decrease in 
carbohydrate oxidation (Figure 3I, J). This occurred in hamsters treated with IMC-H7 maintained in 
both photoperiods, but again the magnitudes of these responses were reduced in the SD-exposed 
hamsters (Figure 3G-J). Fasting blood glucose concentrations were not affected at the end of the 
study (Figure 2H), but fasting insulin (Figure 2I) and leptin (Figure 2J) concentrations were 
significantly lower in hamsters in LD. The insulin response mirrored that following 
intracerebroventricular administration of IMC-H7 (Figure 1K). Insulin concentrations were not 
significantly affected by FGFR1c antagonism in hamsters in SD (Figure 2I), and circulating leptin 
concentrations were close to the limit of detection in all hamsters in SD, so no effect was detected 
(Figure 2J). Clearly systemic treatment with IMC-H7 has potent effects on food intake and body 
weight that resemble the effects of central treatment, so these observations are consistent with the 
view that peripheral treatment with IMC-H7 may also be targeting central FGFR1c. The suppression 
of appetite is consistent with a central action, and it is noticeable that the decrease in circulating 
leptin observed after systemic administration of IMC-H7 is not sufficient to promote a compensatory 
hyperphagic response. 
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 We found no evidence of altered FGFR1c gene expression in the ependymal cell layer of 
hamsters in LD and SD (Figure S1) that might explain the differential responses to FGFR1c 
antagonism. We considered that these differential responses to IMC-H7 in LD and SD could therefore 
either be due to the reduced peripheral adiposity of hamsters in the SD state (e.g. epididymal fat 
reduction of ~20%), or could be a reflection of the underlying photoperiodically-regulated central 
state. To distinguish these two possibilities, we tested the effects of IMC-H7 in hamsters in which 
peripheral fat loss was caused by caloric restriction for 5 weeks rather than by exposure to a SD 
photoperiod (Figure S3). Clear catabolic responses to IMC-H7 were observed that resembled those 
previously observed in fat hamsters in LD (Figure S3), suggesting that central photoperiodic state 
rather than peripheral adiposity was the key factor determining the response to FGFR1c blockade.  
 
Hypothalamic gene expression after FGFR1c blockade 
To understand better how blockade of FGFR1c might affect tanycyte function, we used in situ 
hybridization to assess expression of DIO2 and DIO3 after IMC-H7 treatment. These genes  are 
pivotal in the seasonal regulation of energy balance by virtue of their regulation of the local 
availability of tri-iodothyronine [18]. As previously reported, there was clear mRNA expression for 
both DIO2 and DIO3 in the ependymal layer surrounding the ventral third ventricle, and short day 
exposure reduced DIO2 mRNA expression by 3-fold but hugely increased DIO3 expression (Figure 4A-
D). Importantly, treatment of hamsters in LD with IMC-H7 resulted in a 2-fold decrease in DIO2 
mRNA expression (P<0.001) when compared to vehicle-treated hamsters (Figure 4A, B). There were 
no effects of treatment on DIO3 mRNA expression in animals maintained in either LD or SD (Figure 
4A-D). This clear decrease in DIO2 expression in the ependymal cell layer was also observed in the 
study where previously food-restricted hamsters in LD were treated with IMC-H7 (Figure 4E, F). The 
decrease in DIO2 expression would be expected to cause a reduction in local tri-iodothyronine (T3) 
availability in the surrounding hypothalamus [19]. We have previously observed that local delivery of 
T3 into the hypothalamus via slow-release microimplants causes increased food intake, reduced 
energy expenditure, and thus increased body weight in hamsters [20], so the reverse responses 
observed after IMC-H7 treatment in the current study are consistent with the reduction in DIO2 
expression and in T3 availability. 
We also analysed a number of other genes in the hypothalamus implicated in the control of food 
intake and energy expenditure. NPY, AgRP, POMC and CART mRNA expression were highly localized 
to the arcuate nucleus (ARC) and TRH and CRH mRNA were highly expressed in the PVN, but there 
were no effects of photoperiod or IMC-H7 treatment on any of these known homeostatic regulators 
of energy balance (Figure 4H, Figure S4). There was a significant increase in somatostatin (SRIF) 
mRNA abundance in the ARC following IMC-H7 treatment though the magnitude of increase was not 
as great as that induced by exposure to SD (Figure S4). The SD-induced increase in SRIF has been 
observed previously in hamsters [21, 22], and is likely to contribute to the development of the SD 
phenotype [23], so the increase in SRIF may be one of the downstream mediators of the catabolic 
response resulting from FGFR1c blockade. Collectively, these observations indicate that the effects 
of IMC-H7 on DIO2 expression are very specific to the ependymal cell layer, consistent with the view 
that FGFR1c signalling is specific to tanycytes. Given the previous evidence that photoperiod 
regulates deiodinase gene expression in tanycytes, we should view these cells as a locus that 
integrates both photoperiodic and other nutritional and metabolic signals to regulate energy 
balance. 
 
Conclusions 
Our observations in hamsters concur with previous studies in mice, rats and rhesus monkeys that 
antibody-mediated inhibition of FGFR1c decreases food intake and body weight [2], and extend our 
understanding in two important directions. First, they provide evidence that the effects of IMC-H7 
may be mediated centrally via regulation of tanycyte function. FGFR signalling in primary cultures of 
tanycytes was blocked by IMC-H7, and in vivo treatment with IMC-H7 significantly reduced DIO2 
expression in the ependymal cell layer, whereas gene expression encoding homeostatic peptides 
(NPY, AgRP, POMC, CART [24]) was unaffected. It has been previously suggested that the effects of 
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IMC-H7 on food intake are likely to be central on the grounds that a similar antibody (IMC-A1) bound 
to the median eminence/mediobasal hypothalamus in mice [2]. We found that ICV infusion of IMC-
H7 directly into the hypothalamic third ventricle significantly decreased body weight at an 
approximately 200-fold lower dose than that required via peripheral administration, again consistent 
with a local site of action within the hypothalamus.  
Second, we found that the effect of FGFR1c inhibition on caloric intake was greater in hamsters in 
the LD fat state when compared to those in the SD lean state, suggesting that activity of the FGFR1c 
system might vary as a function of either adiposity or photoperiod. One interpretation of these 
findings might be that adipose tissue is a direct target of IMC-H7, thus fat hamsters in LD would 
show an enhanced response. White adipose tissue expresses FGFR1c, and targeted knockout of this 
receptor from adipocytes greatly reduces the responsiveness of mice to FGF21, a ligand for FGFR1c 
[25]. However, the effects of FGFR1c blockade in calorically-restricted hamsters in LD whose fat 
stores had been depleted to levels characteristic of SD hamsters were comparable to those in 
hamsters in LD on ad libitum diet. This suggests that photoperiod rather than peripheral adiposity is 
the more important determinant of the effects of FGFR1c blockade, so it is changes in central state 
that determine the response to IMC-H7, that is, the primary actions of IMC-H7 are central rather 
than peripheral. This interpretation is reinforced by the striking effects of FGFR1c blockade on DIO2 
gene expression in the hypothalamus, as changes in expression of hypothalamic deiodinases are a 
key mechanism underlying photoperiodic regulation of cycles of appetite and metabolism [4]. 
Although the predominant form of circulating thyroid hormone is the relatively inactive precursor 
thyroxine (T4), it is the tanycyte-specific expression of the MCT8 transporter and of deiodinase 
enzymes that regulate local bioactive T3 availability in the hypothalamus [26, 27]. The reduction in 
food intake that occurs when switching Siberian hamsters from LD to SD is primarily associated with 
the reduction in hypothalamic thyroid hormone availability resulting from decreased expression of 
DIO2 and a reciprocal increase in DIO3 expression in the ependymal tanycyte layer [7, 20]. In the 
current study, the IMC-H7-mediated reduction in daily food intake was associated with a significant 
decrease in DIO2 mRNA expression in the ependymal tanycyte layer when hamsters were housed in 
LD, but not in SD when DIO2 expression was already reduced. Likewise, there was a significant 
decrease in DIO2 mRNA expression in the ependymal tanycyte layer of the mediobasal 
hypothalamus in food-restricted animals treated with IMC-H7 when compared to vehicle. Thus, 
antibody-mediated inhibition of food intake is associated with a reduction in DIO2 mRNA expression 
in the tanycyte layer of the mediobasal hypothalamus regardless of the prevailing adiposity. 
Furthermore, it seems that the blunted responses to IMC-H7 treatment in animals maintained in SD 
may be due to the already reduced mRNA expression of DIO2 in the mediobasal hypothalamus. The 
mechanism of action of thyroid hormone on appetite remains to be determined, but the increased 
expression of SRIF may be one potential pathway. There is also robust evidence in mice that fasting 
induces DIO2 expression and increases T3 concentrations in the mediobasal hypothalamus, and that 
the glial elements expressing DIO2 are closely apposed to NPY/AgRP neurons in the ARC [28]. The 
increase in T3 was demonstrated to promote mitochondrial uncoupling and increase neuronal 
excitability in these orexigenic NPY/AgRP neurons via an uncoupling protein 2 mechanism [28]. 
Conversely, a decrease in DIO2 expression and therefore T3 availability might be expected to reduce 
NPY/AgRP activity, which would then contribute to the decreased food intake we observed after 
FGFR1c blockade. Collectively, we consider that our in vitro and in vivo observations provide 
evidence that FGFR1c signalling in tanycytes and subsequent regulation of local thyroid hormone 
availability is a physiologically important mechanism in the regulation of appetite.  
 
Experimental Procedures 
Supplemental information including detailed experimental procedures and four figures and can be 
found with this article online at… 
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Figure 1. A monoclonal Ab raised against FGFR1c blocks signal transduction in tanycytes and elicits 
physiological responses in vivo after central infusion 
 A in situ hybridization of a 35S labelled probe for FGFR1c on a coronal section through the 
mediobasal hypothalamus of a Siberian hamster maintained in LD, arrow indicates ependymal region 
surrounding the third ventricle; emulsion-coated slide showing silver grains arising from 
hybridization of a FGF1Rc probe (3V = third ventricle). B Western blots showing ERK1/2 
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phosphorylation following treatment with 10nM FGF2, antibody IMC-H7 (H7) or pre-treatment with 
H7 followed by 10nM FGF2. Each blot is one representative experiment out of three.  C mean (±SEM) 
values, normalized to total ERK1/2, n=6 per treatment, ***p<0.001 vs vehicle.  D Western blots 
showing Akt phosphorylation, samples as for B.  E mean (±SEM) values, normalized to total Akt, n=6 
per treatment, ***p<0.001 vs vehicle.  F changes in body weight in adult male hamsters that 
received an intracerebroventricular (ICV) infusion of 0.5g IMC-H7 (n=7) or vehicle (n=8), **p<0.01, 
***p<0.001 vs vehicle. G daily food intake in hamsters receiving ICV IMC-H7 or vehicle, ***p<0.001 
vs vehicle. H calculated energy expenditure and I fat oxidation (FOX) in vehicle and IMC-H7 treated 
hamsters from 72-96 hours after the ICV infusion, *p<0.05 vs vehicle. Solid bars (H, I) indicate dark 
phase. J plasma leptin and K insulin concentrations 96 hours after treatment, ***p<0.001 vs vehicle. 
See also Figure S1 for analysis of FGFR1 gene expression in LDS vs SD. 
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Figure 2. Systemic treatment with a monoclonal Ab raised against FGFR1c increases fat oxidation and 
promotes weight loss 
A changes in body weight and B daily food intake in adult male hamsters in LD treated 
subcutaneously with vehicle () or increasing doses of IMC-H7 (  0.3 mg/kg, ● 1.0 mg/kg, ● 3 mg/kg) 
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and monitored for 11 days, values are group mean ± SEM, n=4 per treatment, *p<0.05, **p<0.01 
and ***p<0.001 vs vehicle. Hamsters were placed in metabolic cages (CLAMS) 5 days after vehicle or 
IMC-H7 treatment, values shown are hourly mean ± SEM values calculated for energy expenditure 
(C), fat oxidation (FOX: D) and carbohydrate oxidation (COX: E) from day 6-7 after treatment; 
*p<0.05 and ***p<0.001 main effect of treatment vs vehicle. F: representative CT scan images 
before and 7 days after vehicle or 3 mg/kg IMC-H7 treatment, blue shading indicates values above 
200 Hounsfield units. G whole body fat mass derived from microCT, values are group mean (± SEM), 
n=6 per group, *p<0.05 vs vehicle.  Blood glucose (H), insulin (I) and leptin (J) concentrations in age-
matched adult male hamsters maintained in long or short days for 12 weeks then treated with 
vehicle of IMC-H7 (3 mg/kg) for 72 hours, values are group mean  (± SEM), n=6-8 per group, 
***p<0.001 vs vehicle, ooop<0.001 vs long day values. See also Figure S2 for effects of IMC-H7 in 
short days (SD). 
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Figure 3. Suppression of food intake and increases in fat oxidation in response to FGFR1c blockade 
are more pronounced in hamsters in the long day fat state  
Upper panels: change in body weight in age-matched adult male hamsters in LD (A) or exposed to 12 
weeks of SD (B) treated with vehicle () or IMC-H7 (● 3 mg/kg). Corresponding food intake is shown 
below in panels C (LD) and D (SD). Values are group mean ± SEM, n=6 per treatment, *p<0.05, 
**p<0.01 and ***p<0.001 vs vehicle. Lower panels: analysis of metabolic cage (CLAMS) data after 
vehicle () or IMC-H7 treatment (● 3 mg/kg). Hourly mean ± SEM values were calculated for energy 
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expenditure (E LD, F SD), fat oxidation (FOX: G LD, H SD) and carbohydrate oxidation (COX: I LD, J 
SD), from 48-72 hours after treatment, ***p<0.001 main effect of treatment vs vehicle (treatment x 
time interaction in panel E). See also Figure S3 for effects of IMC-H7 in hamster in LD previously 
food-restricted to reduce adiposity. 
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Figure 4. Responses to FGFR1c blockade are associated with suppression of deiodinase 2 gene 
expression in tanycytes in the hypothalamic ependymal cell layer 
Representative autoradiographic film images from adult male hamsters in long days (LD) or short 
days (LD) revealing DIO2 (A) and DIO3 (C) mRNA distributions and relative density (B DIO2 , D DIO3) 
of hybridization signal 7 days after treatment with vehicle () or 3 mg/kg IMC-H7 (). Values are 
group mean ± SEM, n=6 per group, ***p<0.001 vs vehicle, oop<0.01 vs long day values. E 
autoradiographic film images revealing DIO2 from vehicle and IMC-H7-treated adult male hamsters 
in LD that had previously been calorically restricted such that their body weight and adiposity was 
comparable to SD-exposed hamsters. F relative density of hybridization signal around the third 
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ventricle after 3 days treatment with vehicle () or IMC-H7 (). Values are group mean ± SEM, n=6 
per group, *p<0.05 vs vehicle. G representative autoradiographic images and H relative density of 
signal for NPY mRNA in hamsters in LD or SD, 7 days after treatment with vehicle () or 3 mg/kg IMC-
H7 (). Values are group mean ± SEM, n=6 per group. Scale bars in lower right panels are 1000µm. 
See also Figure S4 for autoradiographic images and density analysis of other hypothalamic genes. 
 
 
Supplemental Experimental Procedures 
Animals  
Male Siberian hamsters (Phodopus sungorus) were obtained from a breeding colony maintained at 
the University of Nottingham BioSupport Unit [S1].  Studies followed ARRIVE guidelines [S2], and 
were carried out in accordance with the UK Animals (Scientific Procedures) Act of 1986 (project 
licence: PPL 40/3604) and approved by the University of Nottingham Animal Welfare and Ethical 
Review Board. Hamsters were group housed at approximately 21oC and 40% humidity, and were 
allowed ad libitum access to water and standard laboratory chow comprising of 19% protein, 45% 
carbohydrate, 9% fat (Teklad 2019, Harlan, UK). Animals were housed from birth in long day 
conditions (LD) of 16 hours light: 8 hours dark with lights off at 11:00 GMT, short day (SD) exposure 
comprised 8 hours light: 16 hours dark with lights off maintained at 11:00 GMT.   
 
Effects of IMC-H7 on signal transduction in primary cultures of hypothalamic tanycytes 
Primary tanycyte cell cultures were prepared from 8-10 day old Sprague-Dawley rat. Brains were 
collected and micro-dissected in ice-cold Dulbecco’s phosphate buffer saline solution (Sigma Aldrich) 
using a binocular magnifying microscope After the micro-dissection of the median eminence and the 
floor of the third ventricle, or small parts of the cortex as a control region, explants were collected in 
ice-cold Dulbecco’s modified Eagle medium (DMEM; Sigma Aldrich). Explants were pooled and 
dissociated on a 20 μm nylon membrane (Sefar). Cells were cultured in DMEM supplemented with 
10% foetal bovine serum (Sigma Aldrich) on 25 cm2 flasks (Corning Costar or Sigma Aldrich) under 
humid atmosphere of 5% CO2-95% air at 37°C. The initial culture medium was changed after 3 or 4 
days. These procedures have been described previously [S3, S4]. 
 
Effects of central administration of IMC-H7 on body weight, food intake and energy expenditure in 
the Siberian hamster.   
The effects of a single intracerebroventricular (ICV) infusion of IMC-H7 (0.5g in 1l) were 
determined in adult male Siberian hamsters that had been housed in LD since birth. Body weight and 
food intake were recorded on a weekly basis prior to the start of the experimental period. Hamsters 
were singly housed for 7 days prior to surgical preparation. Siberian hamsters were anesthetized 
with isoflurane (1.5%). Analgesia was maintained via sc injection of carprofen (50 mg/kg Rimadyl; 
Pfizer) administered before surgery and daily afterwards during the recovery period. ICV cannulation 
and infusion were carried out as previous described [S5]. Following a 7 day recovery period animals 
received either a single ICV infusion of either saline or IMC-H7 (0.5µg/µl). Body weight and food 
intake were recorded daily. 48 hours after the infusion, animals were transferred to CLAMS for 48 
hours.   
 
Dose-response studies: effect of peripheral administration of IMC-H7 on body weight, food intake 
and energy expenditure 
The effects of IMC-H7 were measured in adult male hamsters that had been housed in LD since birth 
(n=16). Animals from each photoperiod were divided into one of four dose groups and received a 
single subcutaneous injection of either saline (vehicle) or IMC-H7 at a dose of 0.3, 1.0 or 3.0 mg/kg 
(n=4 per group). Body weight and food intake were recorded daily. Five days after the injection 
period animals were transferred to metabolic cages for 48 hours.  This design was then repeated in 
male hamsters that had been transferred to SD at around 3 months of age and studied at ~6 months 
of age at which point body weight and adiposity were markedly reduced. 
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Effect of IMC-H7 treatment on hypothalamic gene expression in relation to body weight, food intake, 
energy expenditure and substrate utilization 
The effects of 3 mg/kg IMC-H7 were measured in age-matched adult male hamsters that had been 
housed in LD since birth or transferred to SD at ~3 months of age.  Animals from each photoperiod 
were divided into one of two treatment groups and received a single subcutaneous injection of 
vehicle (saline) or IMC-H7 (3 mg/kg). After 24 hours hamsters were transferred to metabolic cages 
for the remainder of the study (48 hours). During this time food intake, VO2 and VCO2 were 
measured.  At 72h post treatment the animals were euthanized by injection of sodium 
pentobarbitone (Euthatal: Rhone Merieux, Harlow, UK). Blood samples were collected by cardiac 
puncture for the determination of circulating hormone concentrations, and the brain for dissected 
and frozen on dry ice for subsequent analysis of hypothalamic gene expression.  
 
 
 
Effects of IMC-H7 treatment in calorically-restricted Siberian hamsters  
Five weeks prior to the start of treatment animals were subjected to a restricted food regime. 
Initially a habituation period was implemented in which hamsters were restricted to just 90% of their 
individual ad libitum food intake for 3 days. Following this initial habituation period individual animal 
food intake was reduced by a further 10% for a further 3 days, after which, all animals were 
restricted to 70% of their individual ad libitum food intake until an average body weight loss of at 
least 20% (equivalent to that of SD body weight loss) had been achieved at 5 weeks after the start of 
the restricted diet regimen. Once pre-determined body loss (~20%) had been achieved all animals 
were put back on ad libitum food intake and animals were divided into one of two treatment groups 
(n=6 in each group) in which they received a single subcutaneous injection of either saline or IMC-H7 
(3 mg/kg). Food intake and body weight were recorded on a daily basis. Following 72h of the 
treatment period hamsters were euthanized and the brain was collected for mRNA expression 
analysis.  
   
Whole-body metabolic analysis 
Oxygen consumption (VO2) and carbon dioxide production (VCO2) were measured concurrently at 9-
min intervals using a modified open circuit calorimeter (Comprehensive Laboratory Animal 
Monitoring System:  CLAMS, Linton Instrumentation, Linton, UK and Columbus Instruments, 
Columbus, OH) as described previously [S6]. VO2 and VCO2 were then used to calculate energy 
expenditure and the rate of whole body carbohydrate (COX) and fat (FOX) oxidation, as previously 
described [S7].  
 
In situ hybridization 
Briefly, 20m cryostat sections were fixed in 4% paraformaldehyde in 0.1M-phosphate buffer 
solution, acetylated in 0.25% acetic anhydride in 0.1M-triethanolamine (pH8). After which, 
radionucleotide 35S-labeled isotope probes (~106 counts/min; table 2.2) were applied to the slides in 
70 µl of hybridization buffer containing 0.3 M NaCl, 10 Mm Tris-HCl (Ph 8), 1 Mm EDTA, 0.05% 
transfer RNA, 10 Mm dithiothreitol, 0.02% polyvinylpyrrolidone, 0.02% BSA, and 10% dextran 
sulphate. Radionucleotide isotope probes were left to hybridize over night at 55°C. Slides were then 
washed in a 4 times a sodium citrate solution (1X standard saline citrate = 0.15 M NaCl, 15 mM 
sodium citrate), treated with ribonuclease A (20 μg/μl) at 37°C and were subsequently washed in 
0.1X standard saline citrate solution at 60°C. Finally, radioactive slides were dried and exposed to 
Biomax autoradiographic MR film together with a 14C microscale for 24h – 7 days depending upon 
the activity of the radionucleotide isotope probe being used.     
 
Image analysis  
Radionucleotide intensity analysis was conducted using Image pro PLUS (version 4.1.00, Media 
Cybernetics, Wokingham, UK) analysis software. Briefly, autoradiographic films containing recorded 
images of all experimental slides were scanned at 600dpi on an Umax scanner linked to a PC running 
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Image pro PLUS. For each radionucleotide probe 3 coronal cross sections spanning the selected 
region of the hypothalamus were chosen for image analysis. Integrated optical density for each 
region was obtained by reference to a standard curve generated from the 14C microscale. 
 
microCT: assessment of adiposity 
Hamsters were imaged pre-treatment and post-treatment and the changes in adipose tissue 
volumes determined.  Briefly, computed tomographic (CT) imaging of the hamster torso was carried 
out on Mediso nano-pet/CT under general anesthesia (1.5% isoflurane), using a Helical Tube voltage 
of 45kVP, exposure 600ms, number of projections 360, pitch 1 and 1:4 binning, pixel 96µm. The 
image reconstruction was carried out using Ramlak filter, 100% cut off. To quantify the visceral and 
subcutaneous fat depots, all image analysis was performed with VivoQuant software (inviCRO), 3D 
regions of interest were drawn using the integrated neighbourhood thresholding tool and 
Hounsfield unit definition -500 to +200 to give the volume of fat deposition.  
 
Hormone assays 
ELISA kits (Millipore, MA, USA) were used to measure circulating levels of insulin (rat/mouse kit 
EZRMI-13K) and leptin (mouse kit EZML-82K) in plasma samples.  Blood glucose was measured using 
a HemoCue 201 system (Angelholm, Sweden). 
 
Statistical analysis 
Descriptive statistics (mean ± SEM) were generated using GraphPad Prism (Prism 6.0, GraphPad, San 
Diego, CA).  Body weight, food intake and CLAMS data were analyzed using a two-way (treatment x 
sampling time) repeated measures ANOVA, with Bonferroni corrections used as a post-hoc test. 
Tissue weights, gene expression analysis and protein abundance were analysed using one-way 
ANOVA or student unpaired t-test where appropriate.  Statistical significance was declared at 
P<0.05. 
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